OVERVIEW

Management of Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention is organized by American College of Cardiology (ACC).

Released Date: Nov 26, 2019
Expiration Date: Nov 26, 2020

Accreditation:
Physicians
• The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
• The ACCF designates this enduring material for a maximum of up to .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

MOC:
• Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Description:
This activity was planned with a goal to improve your competence in evaluating and managing patients with concomitant coronary artery disease and atrial fibrillation.

Learner Objectives:
Upon completion of this program, you should be able to:
• Identify the optimal management of antiplatelet therapy and anticoagulation in patients with atrial fibrillation who undergo percutaneous coronary intervention.